Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
pegaspargase
pegaspargase
Brand names: Oncaspar
| Form | Strength |
|---|---|
| SOLUTION, INJECTABLE | 750 intl units/mL |
Last updated: Jan. 18, 2023
- Antineoplastic HD PPE and Disposal
- Antineoplastic HD Hazardous Drug Safe Handling Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
LH Pharmacy Services Admixture Standards
NOTE: Pegaspargase is not listed as a HazD Drug as is was removed from NIOSH list in 2014
Effective December 1, 2022 Servier Pharmaceuticals LLC will no longer offer Oncaspar (pegaspargase) for patients aged 1 month up to 21 years of age, but
instead, will offer Asparlas (calaspargase pegol-mknl) for this patient population.